Huadong and MC2 Therapeutics Announce Strategic Collaboration for Biomee® Creams in Greater China
MC2 Therapeutics grants Huadong exclusive Greater China rights to PAD Technology® powered Biomee® creams designed to address itch and dry skin. COPENHAGEN, DENMARK, January 5, 2026 /EINPresswire.com/ -- Hangzhou Zhongmei Huadong Pharmaceutical …